-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to Article 83 of the "Drug Administration Law of the People's Republic of China", the State Drug Administration organized a post-marketing evaluation of phenolphthalein tablets and phenolphthalein lozenges.
The evaluation found that phenolphthalein tablets and phenolphthalein lozenges had serious adverse reactions.
The risk of use outweighs the benefit, and it is decided to stop the production, sales and use of phenolphthalein tablets and phenolphthalein lozenges in China from now on, and cancel the drug registration certificate (drug approval number)
.
The phenolphthalein tablets and phenolphthalein lozenges that have been on the market are recalled by the manufacturer, and the recalled products are supervised and destroyed by the drug regulatory authority where the company is located
.
Hereby announce
Attachment: List of manufacturers of phenolphthalein tablets and phenolphthalein lozenges
State Food and Drug Administration
January 8, 2021
Annex to Announcement No.